May 3, 2024

Major new study: Hormone therapy benefits outweigh risks in menopause

A recent study published in JAMA suggests that the benefits of hormone therapy outweigh the risks for treating menopause symptoms, particularly among women under 60.

April 26, 2024

Mass confusion: Our letter

This week, APC submitted a comment letter to the Massachusetts Board of Pharmacy about two issues on which the Board recently expressed concern.

April 26, 2024

APC to regulators: The stability study backlog is real

This week, APC wrote to state boards of pharmacy and FDA to make them aware of delays in completing stability studies as USP 797 is enforced across the country.

April 26, 2024

Welcome, Wells Pharmacy

Wells Pharmacy Network is our newest Bronze-level Corporate Patron — a $10,000 investment. 

April 26, 2024

GLP-1 compounding and one-handed reporting

You know this by now: You can’t believe everything you read in the news, especially when it comes to compounding.

April 26, 2024

EduCon is back … as a webinar series

You may know EduCon as APC’s “Ethical Compounding Conference” – a virtual event that delivers “best practices” training to compounding pharmacists and technicians. This year, it’s back with a new user-friendly format.

April 26, 2024

A giant has fallen

With the passing of Dr. Loyd V. Allen, Jr., PhD, this week, our profession lost a giant. No hyperbole here: His passion for and influence over the ethical practice of pharmacy compounding is simply unequalled. 

April 25, 2024

Nonsterile compounders: Check your water

Be aware: FDA has issued a number of 483s related to the water used in nonsterile compounding. Water for nonsterile compounds needs to be USP-grade purified water.

April 25, 2024

New PFM resources

We have several new PFM-only resources now available on our website. Make sure you’re logged in so you can access them.

April 25, 2024

Setting the record straight on compounded GLP-1s

APC’s Scott Brunner and Tenille Davis are guests on the latest GameChangers Pharmacotherapy Podcast, where they cover facts and misinformation around compounded GLP-1s.

« Newer EntriesOlder Entries »